Table 1.
Feature | TLE-P (n = 20) | TLE-NonP (n = 29) | Healthy (n = 42) | p-value |
---|---|---|---|---|
Gender (no.) | ||||
Men:women | 9:11 | 15:14 | 21:21 | 0.89* |
Age at the examination (years) | ||||
Mean ± SD | 46.4 ± 12.0 | 45.5 ± 11.7 | 45.8 ± 11.2 | 0.97† |
Disease duration (years) | ||||
Mean onset age ± SD | 16.5 ± 14.8 | 16.2 ± 8.7 | N/A | 0.96‡ |
Mean duration of epilepsy ± SD | 29.9 ± 13.4 | 29.3 ± 12.6 | N/A | 0.87‡ |
Mean onset age of psychosis ± SD | 32.2 ± 16.2 | N/A | N/A | N/A |
Mean duration of psychosis ± SD | 14.2 ± 12.8 | N/A | N/A | N/A |
Clinical features | ||||
Focus side (L:R) | 9:11 | 14:15 | N/A | 0.82* |
Hippocampal sclerosis (no.) | 10 | 15 | N/A | 0.91* |
Patients with FBTCS (no.) | 3 | 4 | N/A | 0.91* |
Patients with FAS (no.) | 8 | 13 | N/A | 0.92* |
Mean frequency of FIAS per month (no.) | 3.15 ± 6.61 | 4.35 ± 6.00 | N/A | 0.51‡ |
Mean number of AEDs ± SD | 2.25 ± 1.02 | 2.66 ± 1.01 | N/A | 0.18‡ |
TLE-P, TLE with psychosis; TLE-NonP, TLE without psychosis group; FBTCS, focal to bilateral tonic-clonic seizures; FAS, focal aware seizures; FIAS, focal impaired awareness seizures; AEDs, anti-epileptic drugs; N/A, not available.
χ2 test,
one-way ANOVA,
unpaired t-test.